We examine the effects of MD–Value in Prevention (MDVIP) enrollment on Medicare expenditures and utilization among fee-for-service beneficiaries with diabetes over a 5-year period.
Lisa Tomai, MS
Advertisement
Articles by Lisa Tomai, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
US Employer Health Care Costs Projected to Rise 9.5% in 2027
2
FDA Clears First Single-Biomarker Blood Test for Alzheimer
3
FDA Approves Nipocalimab-aahu as First Treatment for wAIHA
4
Lung Cancer Task Force Maps Research Roadmap to Close Survival Gap
5